Aesku has completed acquisition of MBL Bion
AESKU.GROUP recently announced completed acquisition of immunofluorescence assay (IFA) specialist MBL BION from MBL Intl., securing their position as the leading provider of IFA solutions to clinical laboratories. The acquisition increases AESKU.GROUP’s addressable market and strengthens its market position.AESKU.GROUP has a track record of developing, producing, and marketing innovative diagnostic assays and automated systems, and […]
